U.S. biotech company Bio Path closes $18.5 million share offering

03/18/2019 9:05:00 AM (GMT)

U.S. oncology-focused biotechnology company Bio-Path Holdings Inc. has completed its previously announced $18.5 million share offering.

The company issued and sold 712,910 shares of its common stock for a price of $25.95 per share.

Bio-Path Holdings plans to use the net proceeds for working capital and general corporate purposes.

U.S. investment bank H.C. Wainwright & Co. acted as the exclusive placement agent for the offering.

Bio-Path Holdings Inc.

All success stories are prepared by Investsize editors which is selecting elite and remarkable information from press releases and anonymous news sources.There is no charge applied for any success stories which is published . Those published success stories are not investment advices and doesnt offer recommendations Alternate Text